cyc 202 has been researched along with 3-methylcholanthrene in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (3-methylcholanthrene) | Trials (3-methylcholanthrene) | Recent Studies (post-2010) (3-methylcholanthrene) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 7,215 | 1 | 158 |
| Protein | Taxonomy | cyc 202 (IC50) | 3-methylcholanthrene (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.3 | |
| Adenosine receptor A3 | Homo sapiens (human) | 5.544 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.544 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.544 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arisan, ED; Coker-Gurkan, A; Guvenir, E; Obakan, P; Unsal, NP | 1 |
1 other study(ies) available for cyc 202 and 3-methylcholanthrene
| Article | Year |
|---|---|
Inhibition of autophagy by 3-MA potentiates purvalanol-induced apoptosis in Bax deficient HCT 116 colon cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; bcl-2-Associated X Protein; Blotting, Western; CDC2 Protein Kinase; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Cyclin-Dependent Kinases; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Immunoprecipitation; Membrane Potential, Mitochondrial; Methylcholanthrene; Purines; Roscovitine; Tumor Cells, Cultured | 2014 |